Future of Pharmacy

Changing the way pharmacists and pharmacy staff think about themselves is key, although providers, payers, and patients must also change how they view the value of pharmacy services.

Benjamin Brown of Standardizing Laboratory Practices in Pharmacogenomics (STRIPE) discusses his own experience as a patient with cancer and how consensus around pharmacogenomic practices can improve the lives of patients.

Although respondents identified some exciting areas of growth, challenges remain, including the complex insurance system and ensuring patient medication adherence.

Legislative efforts in the states and Washington, DC, have made progress, but there is still a way to go.

Artificial intelligence (AI) is transforming drug development by automating routine tasks, enhancing clinical trials, and expediting drug discovery, ultimately leading to more personalized treatments.

It is valuable for pharmacists to understand exactly how price transparency data are sourced, what information can be found, antitrust concerns, and implications for the pharmaceutical industry.

Alan Corley, pharmacy owner in Greenville, TN, reflects on the changes he's witnessed throughout his career and the most rewarding aspects of his profession.

As the end of this Congress approaches, the National Community Pharmacists Association is lobbying members to pass pharmacy benefit manager reforms.

Shifting from a vertical, isolated care model into a collaborative approach can improve the clinician and patient experience.

Three of the largest pharmacy benefit managers ––Express Scripts, Optum, and Caremark––are listed in the suit.

With the end of the PREP Act provisions approaching, we want to understand how pharmacists feel about their scopes of practice in each state, and what they think about the future of the profession.

Incorporating AI into pharmacy education is crucial to training on its appropriate use.

Fred Barton discusses the role of PBMs in making prescription drug decisions.

Breanne Peyton-Thomas, PharmD, BCOP, discusses her work as a pharmacist at Ochsner Health on the CAR T-cell therapy team.

Discount Drug Mart's new pharmacists are excited about the expanding role of community pharmacy in providing personalized, patient-centric health care.

High-cost novel therapies challenge payers and patients, while biosimilars help balance affordability.

Jake Galdo and Annie Eisenbeis discuss their vaccine gap closure program and the ability to utilize the model beyond vaccines.

Eight areas of improvement were developed as part of national initiative with stakeholder involvement.

For pharmacies, AI and other technologies are key to thriving in the era of value-based care.

In Missouri, community health workers partnered with community pharmacists, CPESN, and others to develop a state-funded program to address vaccine gaps in local communities.

In an interview with Pharmacy Times, Jasmine Perry describes her idea of an effective health care delivery model and why research can have a huge impact at the policy level.

Drawing on years of experience, Rina Shah explains how sustainable care models are essential for a thriving pharmaceutical industry.

When a community loses a pharmacy, it loses a trusted health care provider. Understanding the root causes of these closures—and what we can do about it—can drive change.

The decision by the Supreme Court has the potential to upend the power of regulatory agencies to shape the health care landscape of the country.

In a session at NACDS Total Store Expo, experts spoke to the success of value-based care models in the pharmaceutical industry.